The Mayo Nephrology Collaborative Group (MNCG) develops and conducts studies aimed at treating people with renal parenchymal diseases, including FSGS. The MNCG is a consortium of nephrologists from Mayo Clinic in Minnesota, Florida and Arizona and from other centers across the United States interested in researching treatments for renal parenchymal diseases.
See a list of publications by Mayo doctors on FSGS on PubMed, a service of the National Library of Medicine.
March 20, 2014
- Focal glomerulosclerosis. National Kidney Foundation. http://www.kidney.org/atoz/content/focal.cfm. Accessed Aug. 20, 2013.
- FSGS: Focal segmental glomerulosclerosis. NIH Rare Diseases Clinical Research Network. https://rarediseasesnetwork.epi.usf.edu/neptune/patients/learnmore/fsgs/. Accessed Aug. 20, 2013.
- D'Agati VD, et al. Focal segmental glomerulosclerosis. New England Journal of Medicine. 2011;365:2398.
- Ponticelli C, et al. Current and emerging treatments for idiopathic focal and segmental glomerulosclerosis in adults. Expert Review of Clinical Immunology. 2013;9:251.
- Cook AJ. Decision Support System. Mayo Clinic, Rochester, Minn. July 23, 2013.
- Find a transplant center. Scientific Registry of Transplant Recipients. http://www.srtr.org/csr/current/Centers/Default.aspx. Accessed Aug. 27, 2013.
- Thomas LF (expert opinion). Mayo Clinic, Phoenix/Scottsdale, Ariz. Oct. 1, 2013.
- Anderson CF (expert opinion). Mayo Clinic, Rochester, Minn. Oct. 6, 2013.